Plasma kallikrein Activators are a diverse group of compounds that indirectly or directly enhance the proteolytic and physiological functions of Plasma kallikrein. Bradykinin, a peptide substrate for Plasma kallikrein, upon cleavage, stimulates antithrombotic pathways that augment the activity of Plasma kallikrein, while High-molecular-weight kininogen serves as both a cofactor and substrate, its cleavage leading to processes like increased vascular permeability and vasodilation. Zinc Chloride acts as a crucial cofactor, enhancing Plasma kallikrein's proteolytic activity by maintaining the protease's active conformation. Similarly, D-Sorbitol acts as an osmolyte, ensuring protein stability and optimal enzymatic activity. Ethanolamine modifies membrane fluidity, facilitating the interaction of Plasma kallikrein with membrane-associated substrates and cofactors, while the dipeptide Lys-Leu may increase Plasma kallikrein's catalytic efficiency through allosteric modulation.
Further, sub-inhibitory concentrations of Benzamidine can induce structural changes that improve substrate accessibility to Plasma kallikrein's active site. Argatroban indirectly increases Plasma kallikrein's function by preserving bradykinin levels through thrombin inhibition, which in turn supports the feedback activation of Plasma kallikrein. The protective role of Soybean trypsin inhibitor extends the functional lifespan of Plasma kallikrein by preventing its proteolytic inactivation. Phosphatidylserine provides a membrane surface that enhances Plasma kallikrein's substrate interactions, boosting its activity. Epsilon-aminocaproic acid, a lysine analog, indirectly sustains Plasma kallikrein's activity by impeding the degradation of kallikrein-kinin system components. Lastly, Nafamostat, a broad-spectrum protease inhibitor, can at certain concentrations potentially enhance Plasma kallikrein activity by preventing the inactivation of crucial pathway constituents. These activators, by influencing various biochemical pathways and processes, collectively contribute to the enhanced activity of Plasma kallikrein, playing a vital role in its physiological functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc is a cofactor necessary for the optimal activity of many proteases, including Plasma kallikrein. Zinc chloride can enhance the proteolytic activity of Plasma kallikrein by stabilizing its active conformation and maintaining the structural integrity of its active site. | ||||||
D-Sorbitol | 50-70-4 | sc-203278A sc-203278 | 100 g 1 kg | $29.00 $69.00 | ||
D-Sorbitol can act as an osmolyte that stabilizes proteins in their native form. The presence of D-Sorbitol may enhance the enzymatic activity of Plasma kallikrein by promoting a favorable conformation for its proteolytic function. | ||||||
Ethanolamine | 141-43-5 | sc-203042 sc-203042A sc-203042B | 25 ml 500 ml 2.5 L | $22.00 $56.00 $204.00 | 1 | |
Ethanolamine can influence the local lipid environment of membrane-bound proteins. By integrating into the phospholipid bilayer, ethanolamine can modify membrane fluidity and potentially enhance the interaction and activity of Plasma kallikrein with its substrates and cofactors on the cell surface. | ||||||
Argatroban | 74863-84-6 | sc-201310 sc-201310A | 10 mg 50 mg | $117.00 $469.00 | 13 | |
Argatroban is a thrombin inhibitor that can indirectly enhance the activity of Plasma kallikrein by reducing the degradation of bradykinin, one of its products. By inhibiting thrombin, argatroban decreases the breakdown of bradykinin, allowing it to exert its physiological effects longer, which in turn can increase the feedback activation of Plasma kallikrein. | ||||||
Trypsin Inhibitor, soybean | 9035-81-8 | sc-29129 sc-29129A sc-29129B sc-29129C sc-29129D sc-29129F sc-29129E | 50 mg 250 mg 1 g 5 g 10 g 25 g 100 g | $41.00 $135.00 $288.00 $1100.00 $1600.00 $2600.00 $10500.00 | 14 | |
Soybean trypsin inhibitor can inhibit trypsin and other serine proteases that could degrade or inactivate Plasma kallikrein. By protecting Plasma kallikrein from proteolytic degradation, this inhibitor can indirectly increase the functional lifespan and activity of Plasma kallikrein in the bloodstream. | ||||||
L-α-Lecithin, Egg Yolk, Highly Purified | 8002-43-5 | sc-203096 | 250 mg | $135.00 | ||
Phosphatidylserine is a phospholipid that can provide a suitable membrane surface for the binding and activation of Plasma kallikrein. By enhancing the interaction between Plasma kallikrein and the cell membrane, phosphatidylserine can increase the protease's activity towards its substrates. | ||||||